A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma. (Q55474585)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

4

S L Safgren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Bernd Walter Scheithauer

5

object named as

B W Scheithauer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

J M Reid

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P J Novotny

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

P S Johnson

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Nair

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R F Morton

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

A K Hatfield

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J E Krook

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M M Ames

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

J C Buckner

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

North Central Cancer Treatment Group

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuro-Oncology

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

255-261

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11212905%20AND%20SRC:MED&resulttype=core&format=json

Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group

4 November 2019

cites work

1 reference

12 December 2020

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

1 reference

12 December 2020

Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma

1 reference

12 December 2020

Pharmacobiochemistry of arylalkyltriazenes and their application in cancer chemotherapy

1 reference

12 December 2020

Role of DTIC (NSC-45388) in the chemotherapy of sarcomas

1 reference

12 December 2020

Phase II evaluation of infusional etoposide and cisplatin in patients with recurrent astrocytoma

1 reference

12 December 2020

Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials

1 reference

12 December 2020

Epigenetic effects of the methylating agent 5-(3-methyl-1-triazeno) imidazole-4-carboxamide in human melanoma cells.

1 reference

12 December 2020

The basis for current treatment recommendations for malignant gliomas

1 reference

12 December 2020

Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide

1 reference

12 December 2020

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

12 December 2020

Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma.

1 reference

12 December 2020

Pharmacokinetics of 3-methyl-(triazen-1-yl)imidazole-4-carboximide following administration of temozolomide to patients with advanced cancer

1 reference

12 December 2020

Phase II North Central Cancer Treatment Group study of 2-cholorodeoxyadenosine in patients with recurrent glioma.

1 reference

12 December 2020

Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Iodine-125 interstitial irradiation for cerebral gliomas

1 reference

12 December 2020

Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine

1 reference

12 December 2020

Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea.

1 reference

12 December 2020

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

12 December 2020

The Role of Radiosurgery in the Treatment of Malignant Brain Tumors

1 reference

12 December 2020

Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults

1 reference

12 December 2020

Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer

1 reference

12 December 2020

Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.

1 reference

12 December 2020

Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441)

1 reference

12 December 2020